Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Mayeux

Showing results (121-130 of 325) with videos related to

Pageof 33
Sort By:
Archives of Neurology|July 1, 1995
The frequency and associated risk factors for dementia in patients with Parkinson's diseaseK Marder, M X Tang, L Cote, et al.
Neurology|February 12, 2004
Genetic influences on memory performance in familial Alzheimer diseaseJ H Lee, A Flaquer, Y Stern, et al.
Kidney International|December 1, 1991
Receptor-mediated increase in cytosolic calcium in LLC-PK1 cells by platelet activating factor and thromboxane A2N Ueda, P R Mayeux, P D Walker, et al.
Neurology|October 1, 1987
Predictors of disease course in patients with probable Alzheimer's diseaseY Stern, R Mayeux, M Sano, et al.
Lancet (London, England)|August 6, 1994
Increased risk of Alzheimer's disease in mothers of adults with Down's syndromeN Schupf, D Kapell, J H Lee, et al.
Annals of Neurology|February 1, 1989
Gray-matter degeneration in presenile Alzheimer's diseaseI Prohovnik, G Smith, H A Sackeim, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1989
Human erythroleukemia cells express functional thromboxane A2/prostaglandin H2 receptorsP R Mayeux, D E Mais, C Carr, et al.
Archives of Neurology|March 1, 1997
Mortality from Parkinson diseaseE D Louis, K Marder, L Cote, et al.
Neurology|July 1, 1987
Clinical and biochemical correlates of bradyphrenia in Parkinson's diseaseR Mayeux, Y Stern, M Sano, et al.
Chemical Research in Toxicology|June 24, 1998
Nitrotyrosine-protein adducts in hepatic centrilobular areas following toxic doses of acetaminophen in miceJ A Hinson, S L Pike, N R Pumford, et al.
Pageof 33

Showing results (121-130 of 325) with videos related to

Sort By:
Pageof 33
Archives of Neurology|July 1, 1995
The frequency and associated risk factors for dementia in patients with Parkinson's diseaseK Marder, M X Tang, L Cote, et al.
Neurology|February 12, 2004
Genetic influences on memory performance in familial Alzheimer diseaseJ H Lee, A Flaquer, Y Stern, et al.
Kidney International|December 1, 1991
Receptor-mediated increase in cytosolic calcium in LLC-PK1 cells by platelet activating factor and thromboxane A2N Ueda, P R Mayeux, P D Walker, et al.
Neurology|October 1, 1987
Predictors of disease course in patients with probable Alzheimer's diseaseY Stern, R Mayeux, M Sano, et al.
Lancet (London, England)|August 6, 1994
Increased risk of Alzheimer's disease in mothers of adults with Down's syndromeN Schupf, D Kapell, J H Lee, et al.
Annals of Neurology|February 1, 1989
Gray-matter degeneration in presenile Alzheimer's diseaseI Prohovnik, G Smith, H A Sackeim, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1989
Human erythroleukemia cells express functional thromboxane A2/prostaglandin H2 receptorsP R Mayeux, D E Mais, C Carr, et al.
Archives of Neurology|March 1, 1997
Mortality from Parkinson diseaseE D Louis, K Marder, L Cote, et al.
Neurology|July 1, 1987
Clinical and biochemical correlates of bradyphrenia in Parkinson's diseaseR Mayeux, Y Stern, M Sano, et al.
Chemical Research in Toxicology|June 24, 1998
Nitrotyrosine-protein adducts in hepatic centrilobular areas following toxic doses of acetaminophen in miceJ A Hinson, S L Pike, N R Pumford, et al.
Pageof 33